Clinical Trials
5 trialsNCT01634685 2020-08-20
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT01323062 2018-12-04
Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01288261 2016-04-21
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
University of Arizona
Phase 1 Completed
NCT00129337 2011-03-01
Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
Peregrine Pharmaceuticals
Phase 1 Completed